Cassandra J. Vandenberg

Statistics

Publications

Citations

3.8K

H-Index

Active since

1998

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

The University of Melbourne

Peter MacCallum Cancer Centre

The Royal Melbourne Hospital

Royal Women's Hospital

Cassandra J. Vandenberg is an author at Walter and Eliza Hall Institute of Medical Research specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

1998–2024

Publications

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized

Mark F. van Delft, Andrew H. Wei, Kylie D. Mason et al. · Cancer Cell · 2006 · 1.2K citations · Full text

Life Sciences, Cell Biology, Pharmacology +10

DNA Damage-Induced Primordial Follicle Oocyte Apoptosis and Loss of Fertility Require TAp63-Mediated Induction of Puma and Noxa

J. B. Kerr, Karla J. Hutt, Ewa M. Michalak et al. · Molecular Cell · 2012 · 267 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair

Wendy L Bridge, Cassandra J. Vandenberg, Roger Franklin et al. · Nature Genetics · 2005 · 209 citations

Life Sciences, Genetics, Molecular Biology +13

Bcl-2, Bcl-xL, and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells

Delphine Mérino, Seong Lin Khaw, Stefan Glaser et al. · Blood · 2012 · 191 citations · Full text

Medicine, Cancer Biology, Cell Biology +9

ABT-199, a new Bcl-2–specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia

Cassandra J. Vandenberg, Suzanne Cory · Blood · 2013 · 189 citations

Medicine, Hematology, Oncology +11

1–5 of 36